Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for knee osteoarthritis pain
ACTRN12619000878178Phase 2Not yet recruiting
- Sponsor
- University of Tasmania
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing Venlafaxine with Placebo (2 arms). Primary endpoint: Change in knee pain on visual analogue scale. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
venlafaxine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12619000878178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000878178.